These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15796261)

  • 1. Presentation of prostate carcinoma with cervical lymphadenopathy: report of three cases.
    Wang HJ; Chiang PH; Peng JP; Yu TJ
    Chang Gung Med J; 2004 Nov; 27(11):840-4. PubMed ID: 15796261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of prostatic adenocarcinoma clinically presenting as supraclavicular and mediastinal lymphadenopathy].
    Tsujino K; Sasada S; Kawahara K; Terada H; Komori C; Suzuki H; Okamoto N; Kobayashi M; Hirashima T; Matsui K; Kawase I
    Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):648-53. PubMed ID: 17763696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine needle aspiration biopsy diagnosis of metastatic prostate carcinoma to inguinal lymph node.
    Rosa M; Chopra HK; Sahoo S
    Diagn Cytopathol; 2007 Sep; 35(9):565-7. PubMed ID: 17703448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical lymph node enlargement on the right side as the initial manifestation of metastatic prostate cancer.
    Ozgür A; Ilker Y; Türkeri LN
    Arch Esp Urol; 2003 Sep; 56(7):859-61. PubMed ID: 14595895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A surprising diagnosis: metastatic prostate cancer causing cervical lymphadenopathy.
    Lad M; Sharma A; Patten DK
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24518391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic prostate carcinoma presenting as supraclavicular lymphadenopathy - is it unusual?
    Ahamed SH; Agarwal AK; Raju PP
    Ann R Coll Surg Engl; 2006 Oct; 88(6):W4-5. PubMed ID: 17059705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supraclavicular lymph node: incidence of unsuspected metastatic prostate cancer.
    Hematpour K; Bennett CJ; Rogers D; Head CS
    Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):872-4. PubMed ID: 16830117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic adenocarcinoma presenting as isolated inguinal lymphadenopathy.
    Doreswamy K; Karthikeyan VS; Nagabhushana M; Shankaranand B
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26153290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate adenocarcinoma manifesting as generalized lymphadenopathy.
    Moura FM; Garcia LT; Castro LP; Ferrari TC
    Urol Oncol; 2006; 24(3):216-9. PubMed ID: 16678051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.
    Schostak M; Krause H; Miller K; Schrader M; Kempkensteffen C; Kollermann J
    BJU Int; 2007 Jun; 99(6):1409-14. PubMed ID: 17428244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum.
    Briganti A; Suardi N; Capogrosso P; Passoni N; Freschi M; di Trapani E; Gallina A; Capitanio U; Abdollah F; Tutolo M; Bianchi M; Salonia A; Da Pozzo LF; Montorsi F; Rigatti P
    Prostate; 2012 Feb; 72(2):186-92. PubMed ID: 21538428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
    Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
    Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.